SCHEMBL10155684

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL10155458	0.91	BACE1 (0.56)	BACE1MAPTRAB9ASMN1; SMN2NPC1
	SCHEMBL10155221	0.89	BACE1 (0.60)	BACE1
	SCHEMBL4085973	0.85	BACE1 (0.64)	BACE1
	SCHEMBL10155088	0.84	BACE1 (0.69)	BACE1
	SCHEMBL4080985	0.84	BACE1 (0.65)	BACE1
	SCHEMBL10155077	0.83	BACE1 (0.79)	BACE1
	SCHEMBL10157534	0.83	BACE1 (0.69)	BACE1
	SCHEMBL15384132	0.83	BACE1 (0.69)	BACE1
	SCHEMBL10156231	0.83	BACE1 (0.69)	BACE1
	SCHEMBL10155483	0.82	BACE1 (0.70)	BACE1MAPTRAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.